Enhancement of the activity of immunotoxins by analogues of verapamil.

Abstract:

:Verapamil has been shown to enhance immunotoxin activity but only at concentrations that are too high for in vivo use. Therefore, four structural analogues of verapamil (D792, D595, D528, and Sz45) were evaluated for their ability to enhance the in vitro activity of immunotoxins made with either ricin A chain or Pseudomonas exotoxin. The following immunotoxins were used: HB21-PE and 454A12-rRTA which recognize the human transferrin receptor; and 260F9-rRTA which reacts with human ovarian carcinoma and breast carcinoma cells. The activities of the immunotoxins were determined in ovarian carcinoma cells and in KB cells using inhibition of either protein synthesis or colony formation as a measure for the cytotoxicity of the immunotoxins. Each of the four analogues enhanced the activity of ricin A-immunotoxins in a dose-dependent manner. D792 and D595 also increased the activity of IIB21-PE. Low concentrations of either Sz45 or D528 enhanced the activity of HB21-PE, but high concentrations of these two analogues either had less enhancing potency than low concentrations or even decreased the activity of HB21-PE. Specificity of enhancement by the analogues was shown by competition of the activity of the immunotoxins by the corresponding antibody and by inactivity of an irrelevant immunotoxin. The amount of enhancement ranged from 2-fold to greater than 60-fold and was dependent on the cell line and on the experimental conditions. The enhancing ability of the drugs did not correlate with their calcium-antagonistic activity. When compared with verapamil, D792 and D595 had greater enhancing potency with regard to both ricin A-immunotoxins and Pseudomonas exotoxin-immunotoxins. Greater enhancing potency and less in vivo toxicity makes D792 a candidate for use in the enhancement of immunotoxins in vivo.

journal_name

Cancer Res

journal_title

Cancer research

authors

Pirker R,FitzGerald DJ,Raschack M,Frank Z,Willingham MC,Pastan I

subject

Has Abstract

pub_date

1989-09-01 00:00:00

pages

4791-5

issue

17

eissn

0008-5472

issn

1538-7445

journal_volume

49

pub_type

杂志文章
  • Differential EphA2 epitope display on normal versus malignant cells.

    abstract::The EphA2 receptor tyrosine kinase is overexpressed in many different types of human cancers where it functions as a powerful oncoprotein. Dramatic changes in the subcellular localization and function of EphA2 have also been linked with cancer, and in particular, unstable cancer cell-cell contacts prevent EphA2 from s...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Coffman KT,Hu M,Carles-Kinch K,Tice D,Donacki N,Munyon K,Kifle G,Woods R,Langermann S,Kiener PA,Kinch MS

    更新日期:2003-11-15 00:00:00

  • The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer.

    abstract::A truncated retinoblastoma (RB) protein of approximately 94 kDa (RB94), lacking the NH2 -terminal 112 amino acid residues of the full-length RB, has been found to have great efficacy in tumor suppression. This study investigated the role of adenovirus-mediated RB94 (Ad-RB94) gene therapy for human head and neck squamo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Li D,Day KV,Yu S,Shi G,Liu S,Guo M,Xu Y,Sreedharan S,O'Malley BW Jr

    更新日期:2002-08-15 00:00:00

  • Hormone binding by human mammary carcinoma.

    abstract::The specific binding of labeled porcine insulin, human prolactin, and human growth hormone was studied in 63 human breast tumors and 15 nonmalignant breast tissues. Most (90%) of the tumors demonstrated significant binding of insulin, as did 80% of nonmalignant tissues. Autoradiographic studies indicated that insulin ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Holdaway IM,Friesen HG

    更新日期:1977-07-01 00:00:00

  • Regulation of transforming growth factor beta 1 action by multiple transducing pathways: evidence for both G protein-dependent and -independent signaling.

    abstract::The effects of cholera toxin (CT) on transforming growth factor beta 1-stimulated protooncogene expression, [gamma-35S]GTP binding, GTPase activity and growth under anchorage-independent and -dependent conditions were studied in AKR-2B fibroblast cells. CT was shown to inhibit TGF beta 1-stimulated c-sis and c-myc mRN...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Howe PH,Bascom CC,Cunningham MR,Leof EB

    更新日期:1989-11-01 00:00:00

  • Dose response of hepatocyte replication in rats following continuous exposure to diethylnitrosamine.

    abstract::Chronic exposure to the hepatocellular carcinogen diethylnitrosamine (DEN) causes a dose-dependent accumulation of the promutagenic DNA adduct O4-ethyldeoxythymidine in hepatocytes and increases in the number of initiated hepatocytes as indicated by gamma-glutamyl transpeptidase positive foci. Initiation is thought to...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Deal FH,Richardson FC,Swenberg JA

    更新日期:1989-12-15 00:00:00

  • Local continuous high dose interleukin 2: a new therapeutic model for the treatment of advanced bladder carcinoma.

    abstract::Because efficient i.v. administration of interleukin 2 (IL-2) in tumor patients leads to severe cardiopulmonary side effects, we developed a new form of IL-2 application that allows activation of all IL-2-responsive immune cells directly at the tumor site. In five patients with T4N0M0 transitional cell carcinoma of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Huland E,Huland H

    更新日期:1989-10-01 00:00:00

  • Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies.

    abstract::Multimodal therapy is generally more effective than single-agent treatment for cancer. rRp450 is an engineered herpes simplex viral mutant that replicates in and kills tumor cells in a relatively selective fashion. It also expresses, in infected cells, the cyclophosphamide (CPA)-sensitive rat cytochrome P450 2B1 (CYP2...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Aghi M,Chou TC,Suling K,Breakefield XO,Chiocca EA

    更新日期:1999-08-15 00:00:00

  • Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.

    abstract::In this study, using the carcinoembryonic antigen (CEA)-expressing C15 murine colon carcinoma system in syngeneic C57BL/6 mice, we have evaluated the efficacy of bone marrow-derived dendritic cells (DCs) pulsed with the murine anti-idiotype antibody 3H1 as a tumor vaccine. Anti-idiotype 3H1 mimics a distinct and speci...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Saha A,Chatterjee SK,Foon KA,Primus FJ,Bhattacharya-Chatterjee M

    更新日期:2003-06-01 00:00:00

  • Protein kinase C delta overexpressing transgenic mice are resistant to chemically but not to UV radiation-induced development of squamous cell carcinomas: a possible link to specific cytokines and cyclooxygenase-2.

    abstract::Protein kinase C delta (PKCdelta), a Ca(2+)-independent, phospholipid-dependent serine/threonine kinase, is among the novel PKCs (delta, epsilon, and eta) expressed in mouse epidermis. We reported that FVB/N transgenic mice that overexpress ( approximately 8-fold) PKCdelta protein in basal epidermal cells and cells of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-2684

    authors: Aziz MH,Wheeler DL,Bhamb B,Verma AK

    更新日期:2006-01-15 00:00:00

  • Cytokinetic and biochemical effects of 5-iminodaunorubicin in human colon carcinoma in culture.

    abstract::The semisynthetic anthracycline, 5-iminodaunorubicin (IM), was investigated to see whether modification of the benzoquinone moiety to produce a drug with low free radical potential would alter the cytotoxic and biochemical characteristics of this drug in comparison to Adriamycin (ADR), an agent with high free radical ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Glazer RI,Hartman KD,Richardson CL

    更新日期:1982-01-01 00:00:00

  • Ionizing radiation activates the Nrf2 antioxidant response.

    abstract::The transcription factor NF-E2-related factor 2 (Nrf2) binds the antioxidant DNA response element (ARE) to activate important cellular cytoprotective defense systems. Recently several types of cancers have been shown to overexpress Nrf2, but its role in the cellular response to radiation therapy has yet to be fully de...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-0171

    authors: McDonald JT,Kim K,Norris AJ,Vlashi E,Phillips TM,Lagadec C,Della Donna L,Ratikan J,Szelag H,Hlatky L,McBride WH

    更新日期:2010-11-01 00:00:00

  • Predicting outcomes in cervical cancer: a kinetic model of tumor regression during radiation therapy.

    abstract::Applications of mathematical modeling can improve outcome predictions of cancer therapy. Here we present a kinetic model incorporating effects of radiosensitivity, tumor repopulation, and dead-cell resolving on the analysis of tumor volume regression data of 80 cervical cancer patients (stages 1B2-IVA) who underwent r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2501

    authors: Huang Z,Mayr NA,Yuh WT,Lo SS,Montebello JF,Grecula JC,Lu L,Li K,Zhang H,Gupta N,Wang JZ

    更新日期:2010-01-15 00:00:00

  • Response to estrogen by the human mammary carcinoma cell line CAMA-1.

    abstract::CAMA-1 cells, isolated from malignant pleural effusion, are grown in long-term cultures as monolayers. The rate of growth is dependent upon fetal bovine serum and estradiol. These cells also exhibit a dose response to added 17 beta-estradiol with respect to the incorporation of radiolabeled thymidine into cells. The u...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Leung BS,Qureshi S,Leung JS

    更新日期:1982-12-01 00:00:00

  • DNA in situ sensitivity to denaturation as a marker of human breast tumors.

    abstract::DNA content and in situ sensitivity to denaturation were analyzed by flow cytometry of individual cell nuclei isolated from 40 breast carcinomas, nine fibroadenomas, and 14 samples of normal breast tissue. The extent of DNA denaturation induced by acid was expressed as alpha t, which represents the fraction of DNA sta...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kunicka JE,Olszewski W,Rosen PP,Kimmel M,Melamed MR,Darzynkiewicz Z

    更新日期:1989-11-15 00:00:00

  • Estrogen receptor expression of benign breast epithelium and its association with breast cancer.

    abstract::We conducted a case-control study of estrogen receptor (ER) and progesterone receptor (PgR) expression in benign breast epithelium from 120 women (51 breast cancer cases and 69 benign disease controls) who underwent breast operations at University Hospital, Syracuse, New York. Benign samples were obtained and processe...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Khan SA,Rogers MA,Obando JA,Tamsen A

    更新日期:1994-02-15 00:00:00

  • Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.

    abstract::Pheochromocytomas are tumors of the adrenal medulla originating in the chromaffin cells derived from the neural crest. Ten % of these tumors are associated with the familial cancer syndromes multiple endocrine neoplasia type 2, von Hippel-Lindau disease (VHL), and rarely, neurofibromatosis type 1, in which germ-line m...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Benn DE,Dwight T,Richardson AL,Delbridge L,Bambach CP,Stowasser M,Gordon RD,Marsh DJ,Robinson BG

    更新日期:2000-12-15 00:00:00

  • Loss of the ceramide transfer protein augments EGF receptor signaling in breast cancer.

    abstract::Triple-negative breast cancers (TNBC) are especially refractory to treatment due to their negative hormone receptor and ErbB2/HER2 status. Therefore, the identification of cancer-associated deregulated signaling pathways is necessary to develop improved targeted therapies. Here, we show that expression of the ceramide...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3069

    authors: Heering J,Weis N,Holeiter M,Neugart F,Staebler A,Fehm TN,Bischoff A,Schiller J,Duss S,Schmid S,Korte T,Herrmann A,Olayioye MA

    更新日期:2012-06-01 00:00:00

  • Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

    abstract::Copper plays an essential role in promoting angiogenesis. Tumors that become angiogenic acquire the ability to enter a phase of rapid growth and exhibit increased metastatic potential, the major cause of morbidity in cancer patients. We report that copper deficiency induced by tetrathiomolybdate (TM) significantly imp...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Pan Q,Kleer CG,van Golen KL,Irani J,Bottema KM,Bias C,De Carvalho M,Mesri EA,Robins DM,Dick RD,Brewer GJ,Merajver SD

    更新日期:2002-09-01 00:00:00

  • Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery.

    abstract::We studied the conditions required for eradication by immunization of occult lymph node metastases which remained after surgical removal of an intradermally transplanted cavian hepatoma. Guinea pigs that received no postsurgical treatment all died with progressively growing lymph node metastases. The growth of these m...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ashley MP,Zbar B,Hunter JT,Rapp HJ,Sugimoto T

    更新日期:1980-11-01 00:00:00

  • The EWS protein is dispensable for Ewing tumor growth.

    abstract::EWS encodes a ubiquitously expressed RNA binding protein with largely unknown function. In Ewing sarcoma family tumors (EFT), one allele is rearranged with an ETS gene. This is the first description of an EFT with a complete EWS deficiency in the presence of two copies of a rearranged chromosome 22 carrying an interst...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kovar H,Jug G,Hattinger C,Spahn L,Aryee DN,Ambros PF,Zoubek A,Gadner H

    更新日期:2001-08-15 00:00:00

  • Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.

    abstract::The prodrug of 9-beta-D-arabinosylguanine (ara-G), nelarabine, demonstrated efficacy against T-cell acute lymphoblastic leukemia, and its effectiveness correlated with the accumulation of the triphosphate form (ara-GTP). Although in vitro investigations using purified deoxycytidine kinase (dCK) or deoxyguanosine kinas...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rodriguez CO Jr,Mitchell BS,Ayres M,Eriksson S,Gandhi V

    更新日期:2002-06-01 00:00:00

  • Tumor-immunotherapeutic efficacy of Serratia marcescens polyribosomes.

    abstract::The ability of polyribosomes, obtained from several bacterial species, to suppress the development of cutaneous SaD2 fibrosarcomas in DBA/2 mice were evaluated. Suppression of tumor appearance depended upon the tumor load at the time of treatment, dose of polyribosomes, and species source of polyribosomes, with Serrat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Urban RW,Edwards BS,Segal W

    更新日期:1980-05-01 00:00:00

  • Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis.

    abstract::miR-31 inhibits breast cancer metastasis via the pleiotropic suppression of a cohort of prometastatic target genes that include integrin alpha(5) (ITGA5), radixin (RDX), and RhoA. We previously showed that the concomitant overexpression of ITGA5, RDX, and RhoA was capable of overriding the antimetastatic effects of ec...

    journal_title:Cancer research

    pub_type: 杂志文章,收录出版

    doi:10.1158/0008-5472.CAN-10-0410

    authors: Valastyan S,Chang A,Benaich N,Reinhardt F,Weinberg RA

    更新日期:2010-06-15 00:00:00

  • A functional screen for germ line p53 mutations based on transcriptional activation.

    abstract::Germ line p53 mutations represent a genetic predisposition for cancer development. At the present time, their detection requires extensive work and their functional significance must be documented. Therefore, we have designed a simple biological assay which detects functionally significant germ line p53 mutations. Thi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Frebourg T,Barbier N,Kassel J,Ng YS,Romero P,Friend SH

    更新日期:1992-12-15 00:00:00

  • Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia.

    abstract::TEL-AML1 gene fusion derived by chromosomal translocation is a common acquired genetic lesion in pediatric cancer that is present in approximately 25% of B-cell precursor acute lymphoblastic leukemias, and recent evidence suggests that this recombination event may initiate leukemogenesis prenatally during fetal hemopo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wiemels JL,Greaves M

    更新日期:1999-08-15 00:00:00

  • Increased level of exon 12 alternatively spliced BRCA2 transcripts in tumor breast tissue compared with normal tissue.

    abstract::The breast cancer susceptibility gene BRCA2 is expressed in a wide range of tissues as an 11-kb mRNA transcript encoding a 3418-amino acid protein, which is involved in the response to DNA damage. To obtain a better molecular characterization of BRCA2 expression in breast tissue, we analyzed full-length BRCA2 mRNA by ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bièche I,Lidereau R

    更新日期:1999-06-01 00:00:00

  • Induction of cytochrome P-450 and 5-aminolevulinate synthase activities in cultured rat hepatocytes.

    abstract::Cytochromes P-450IIB1 and P-450IIB2 were recently shown to be inducible in rat hepatocyte cultures maintained on a reconstituted extracellular tumor matrix (Matrigel) as indicated by increases in P-450IIB1 and -IIB2 mRNAs and immunoreactive proteins (J. Cell. Physiol., 134: 309-323, 1988). Here we show that treatment ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sinclair PR,Bement WJ,Haugen SA,Sinclair JF,Guzelian PS

    更新日期:1990-09-01 00:00:00

  • Toxicity, elimination, and metabolism of 10-ethyl-10-deazaaminopterin in rats and dogs.

    abstract::10-Ethyl-10-deazaaminopterin (10-EdAM) is an antifolate compound with greater therapeutic activity than methotrexate against transplanted tumors in mice. When given weekly for 3 weeks, the 10% lethal dose in rats was 125 mg/kg (i.p.) and in dogs it was 2.5 mg/kg (i.v.). The major histopathological findings in intoxica...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fanucchi MP,Kinahan JJ,Samuels LL,Hancock C,Chou TC,Niedzwiecki D,Farag F,Vidal PM,DeGraw JI,Sternberg SS

    更新日期:1987-05-01 00:00:00

  • Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis.

    abstract::One of the major problems in the diagnosis of localized prostatic tumors is to predict the aggressiveness of an individual tumor, which is presumably associated with chance to progression. In an attempt to find molecular markers that are specific for aggressive prostatic cancer cells, we compared steady-state mRNA lev...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bussemakers MJ,van de Ven WJ,Debruyne FM,Schalken JA

    更新日期:1991-01-15 00:00:00

  • MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway.

    abstract::Despite favorable responses to initial therapy, small-cell lung cancer (SCLC) relapse occurs within a year and exhibits resistance to multiple drugs. Because of limited accessibility of patient tissues for research purposes, SCLC patient-derived xenografts (PDX) have provided the best opportunity to address this limit...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-2874

    authors: Tripathi SC,Fahrmann JF,Celiktas M,Aguilar M,Marini KD,Jolly MK,Katayama H,Wang H,Murage EN,Dennison JB,Watkins DN,Levine H,Ostrin EJ,Taguchi A,Hanash SM

    更新日期:2017-08-15 00:00:00